EMILY ROBERSON: Open Payments
NPI 1245746882 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 14 payments from 7 companies in 2025. Trend: 2023 $688 · 2024 $577 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $156 |
| Ardelyx, Inc. | 1 | $122 |
| Celltrion USA Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: IBSRELA, SKYRIZI, RINVOQ, VEGZELMA, REZDIFFRA, VOQUEZNA, TREMFYA, OMVOH.
Industry payments across AL — which companies pay providers there.
